Navigation Links
Venous origin of the mammalian lymphatic vasculature
Date:9/30/2007

In the October 1 issue of G&D, Dr. Guillermo Oliver (St. Jude Childrens Research Hospital) and colleagues present new evidence to resolve a century-old debate over the origin of the mammalian lymphatic vasculature. Understanding the development of the lymphatic vasculature is integral to understanding its function in both health (mediating immunity and maintaining tissue fluid levels) and disease (lymphedema and spreading tumor metastasis).

The adult mammalian lymphatic vasculature is derived from a few embryonic lymph sacs. The debate has surrounded the cellular origin of the lymphatic vasculature: Does it arise from venous endothelial cells or does it arise in the mesenchyme and then establish venous connection later on in development"

Dr. Oliver and colleagues used genetically modified mice to perform elegant lineage tracing experiments, from which they concluded, quite definitively, that the mammalian lymphatic vasculature is venous-derived.

Identifying the origin of any specific cell type is critical to understand the basic processes guiding the development of an organ. The detailed characterization of the formation of a normal healthy lymphatic vasculature is central to our efforts to prevent, diagnose, and hopefully cure lymphatic vasculature disorders, explains Dr. Oliver.


'/>"/>

Contact: Heather Cosel
coselpie@cshl.edu
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1

Related biology news :

1. Study shows pine bark naturally decreases severe chronic venous insufficiency
2. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
3. Intravenous nanoparticle gene therapy shows activity in stage IV lung cancer
4. UAB scientists discover the origin of a mysterious physical force
5. An (ecological) origin of species for tropical reef fish
6. Ancient DNA helps clarify the origins of two extinct New World horse species
7. International Team Determines Geographic Origin of Leprosy
8. The genetic origins of corn on the cob
9. New Look at DNA Hints at Origin of UV Damage
10. Scientists discover stem cell origin of neck and shoulders
11. Tulane researcher reports on origin of deadly fever outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems is ... log work hours, for employers to make sure the right employees are actually signing ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... Dollar project, for the , Supply and Delivery ... IT Infrastructure , to Decatur ... Identity Management Solutions. Numerous renowned international vendors participated in the ... was selected for the most compliant and innovative solution. The ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Germany on December 6th. Mr. Lubinski will meet ... discuss the benefits of a viscoelastic total disc replacement. , AxioMed received its ...
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Eisai ... 3 open-label two-year study of rufinamide, which were ... American Epilepsy Society (AES) held from December 2-6 ... of final two-year safety, tolerability and cognitive data ... rufinamide experienced similar safety and tolerability profiles, cognitive ...
(Date:12/4/2016)... SAN DIEGO , Dec. 3, 2016  In ... Society of Hematology (ASH) Annual Meeting and Exposition in ... advanced biomedical engineering methods to improve the delivery of ... conditions. These new methods are designed to carry therapies ... are needed most, which could provide a substantial advantage ...
(Date:12/2/2016)... -- Amgen (NASDAQ: AMGN ) and Allergan plc. ... a Marketing Authorization Application (MAA) to the European Medicines Agency ... (bevacizumab). The companies believe this submission is the first ... "The submission of ABP 215 to the EMA is an ... said Sean E. Harper , M.D., executive vice president ...
Breaking Biology Technology: